Cancer Genetics and Epigenetics, 2025, Vol.13, No.2, 62-76 http://medscipublisher.com/index.php/cge 74 Jammula S.J., Katz-Summercorn A.C., Li X., Linossi C., Smyth E., Killcoyne S., Biasci D., Subash V., Abbas S., Blasko A., Devonshire G., Grantham A., Wronowski F., O'Donovan M., Grehan N., Eldridge M., Tavaré S., Fitzgerald R., Noorani A., Edwards P., Nutzinger B., Hughes C., Fidziukiewicz E., Bornschein J., Macrae S., Crawte J., Northrop A., Contino G., Rue R., Miremadi A., Malhotra S., Tripathi M., Lynch A., Eldridge M., Secrier M., Bower L., Devonshire G., Perner J., Jammula S., Davies J., Crichton C., Carroll N., Safranek P., Hindmarsh A., Sujendran V., Hayes S., Ang Y., Preston S., Oakes S., Bagwan I., Save V., Skipworth R., Hupp T., O'Neill J., Tucker O., Beggs A., Taniere P., Puig S., Underwood T., Noble F., Owsley J., Barr H., Shepherd N., Old O., Lagergren J., Gossage J., Davies A., Chang F., Zylstra J., Mahadeva U., Goh V., Ciccarelli F., Sanders G., Berrisford R., Harden C., Lewis M., Cheong E., Kumar B., Parsons S., Soomro I., Kaye P., Saunders J., Lovat L., Haidry R., Igali L., Scott M., Sothi S., Suortamo S., Lishman S., Hanna G., Moorthy K., Peters C., Grabowska A., and Turkington R., 2020, Identification of subtypes of barrett's esophagus and esophageal adenocarcinoma based on dna methylation profiles and integration of transcriptome and genome data, Gastroenterology, 158(6): 1682-1697. https://doi.org/10.1053/j.gastro.2020.01.044. Kato S., Okamura R., Baumgartner J., Patel H., Leichman L., Kelly K., Sicklick J., Fanta P., Lippman S., and Kurzrock R., 2018, Analysis of circulating tumor DNA and clinical correlates in patients with esophageal gastroesophageal junction and gastric adenocarcinoma, Clinical Cancer Research, 24: 6248-6256. https://doi.org/10.1158/1078-0432.CCR-18-1128 Khorfan K., Aljabban J., Syed S., Salhi H., Adejare A., Suara H., Allarakhia Z., Panahiazar M., and Hadley D., 2019, Elucidating the pathogenesis of esophageal adenocarcinoma through meta-analysis of public data, Journal of Clinical Oncology, 37(4 suppl): 71. https://doi.org/10.1200/JCO.2019.37.4_SUPPL.71 Killcoyne S., Yusuf A., and Fitzgerald R.C., 2021, Genomic instability signals offer diagnostic possibility in early cancer detection, Trends in Genetics, 37(11): 966-972. https://doi.org/10.1016/j.tig.2021.06.009 Kumar S., Buon L., Talluri S., Roncador M., Liao C., Zhao J., Shi J., Chakraborty C., Gonzalez G., Tai Y., Prabhala R., Samur M., Munshi N., and Shammas M., 2021, Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma, Communications Biology, 4(1): 617. https://doi.org/10.1038/s42003-021-02125-x Kumar S., Zhao J., Talluri S., Buon L., Mu S., Potluri B., Liao C., Shi J., Chakraborty C., Gonzalez G., Tai Y., Patel J., Pal J., Mashimo H., Samur M., Munshi N., and Shammas M., 2023, Elevated APE1 dysregulates homologous recombination and cell cycle driving genomic evolution tumorigenesis and chemoresistance in esophageal adenocarcinoma, Gastroenterology, 165(2): 357-373. https://doi.org/10.1053/j.gastro.2023.04.035 Lagisetty K.H., McEwen D.P., Nancarrow D., Schiebel J., Ferrer-Torres D., Ray D., Frankel T., Lin J., Chang A., Kresty L., and Beer D., 2020, Immune determinants of barrett's progression to esophageal adenocarcinoma, JCI Insight, 6(1): e143888. https://doi.org/10.1172/jci.insight.143888 Li L., Yuan S., Sun J., Yin Y., Cui J., Zhang J., Chen Y., Pang J., Yin J., Shao Y., and Yu J., 2021, Genomic profiling identified prognostic biomarkers of definitive chemo-radiotherapy response in esophageal carcinoma, International Journal of Radiation Oncology Biology Physics, 111(3S): S13. https://doi.org/10.1016/j.ijrobp.2021.07.061 Li P., Luo H., Chen Y., Wang Y., Chen H., Wu L., Ma Y., and Zhang H., 2019, Immune biomarker expression in the tumor microenvironment in Chinese patients with esophageal squamous cell carcinoma was explored, Journal of Clinical Oncology, 37(15 suppl): e15542. https://doi.org/10.1200/JCO.2019.37.15_SUPPL.E15542 Liu X., Zhang M., Ying S., Zhang C., Lin R., Zheng J., Zhang G., Tian D., Guo Y., Du C., Chen Y., Chen S., Su X., Ji J., Deng W., Li X., Qiu S., Yan R., Xu Z., Wang Y., Guo Y., Cui J., Zhuang S., Yu H., Zheng Q., Marom M., Sheng S., Zhang G., Hu S., Li R., and Su M., 2017, Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma, Gastroenterology, 153(1): 166-177. https://doi.org/10.1053/j.gastro.2017.03.033 Ma S., Zhou B., Yang Q., Pan Y., Yang W., Freedland S., Ding L., Freeman M., Breunig J., Bhowmick N., Pan J., Koeffler H., and Lin D., 2021, A transcriptional regulatory loop of master regulator transcription factors pparg and fatty acid synthesis promotes esophageal adenocarcinoma, Cancer Research, 81: 1216-1229. https://doi.org/10.1158/0008-5472.CAN-20-0652 Maag J., Fisher O., Levert-Mignon A., Kaczorowski D., Thomas M., Hussey D., Watson D., Wettstein A., Bobryshev Y., Edwards M., Dinger M., and Lord R., 2017, Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing, Molecular Cancer Research, 15: 1558-1569. https://doi.org/10.1158/1541-7786.MCR-17-0332 Murugaesu N., Wilson G., Birkbak N., Watkins T., Mcgranahan N., Kumar S., Abbassi‐Ghadi N., Salm M., Mitter R., Horswell S., Rowan A., Phillimore B., Biggs J., Begum S., Matthews N., Hochhauser D., Hanna G., and Swanton C., 2015, Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy, Cancer Discovery, 5(8): 821-831. https://doi.org/10.1158/2159-8290.CD-15-0412 Nagaraja A., Kikuchi O., and Bass A., 2019, Genomics and targeted therapies in gastroesophageal adenocarcinoma, Cancer Discovery, 9(12): 1656-1672. https://doi.org/10.1158/2159-8290.CD-19-0487 Nangraj A.S., Selvaraj G., Kaliamurthi S., Kaushik A.C., Cho W.C., and Wei D., 2020, Integrated PPI-and WGCNA-retrieval of hub gene signatures shared between barrett's esophagus and esophageal adenocarcinoma, Frontiers in Pharmacology, 11: 881. https://doi.org/10.3389/fphar.2020.00881
RkJQdWJsaXNoZXIy MjQ4ODYzNA==